 | • レポートコード：MRC2102QY2014 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の血液脳関門輸送薬市場について種類別（担体輸送、受容体輸送、吸収性輸送、能動排出輸送、その他）、用途別（アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・血液脳関門輸送薬市場の概要 ・世界の主要地域別血液脳関門輸送薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の血液脳関門輸送薬市場規模2015-2026：種類別（担体輸送、受容体輸送、吸収性輸送、能動排出輸送、その他） ・世界の血液脳関門輸送薬市場規模2015-2026：用途別（アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他） ・血液脳関門輸送薬の米国市場規模2015-2020 ・血液脳関門輸送薬のヨーロッパ市場規模2015-2020 ・血液脳関門輸送薬の中国市場規模2015-2020 ・血液脳関門輸送薬の日本市場規模2015-2020 ・血液脳関門輸送薬の東南アジア市場規模2015-2020 ・血液脳関門輸送薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・血液脳関門輸送薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・血液脳関門輸送薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Blood-Brain Barrier Transport Drugs Market
The global Blood-Brain Barrier Transport Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Blood-Brain Barrier Transport Drugs Scope and Market Size
The global Blood-Brain Barrier Transport Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood-Brain Barrier Transport Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Blood-Brain Barrier Transport Drugs market is segmented into
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others
Segment by Application, the Blood-Brain Barrier Transport Drugs market is segmented into
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others
The Blood-Brain Barrier Transport Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Blood-Brain Barrier Transport Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Blood-Brain Barrier Transport Drugs Market Share Analysis
Blood-Brain Barrier Transport Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Blood-Brain Barrier Transport Drugs business, the date to enter into the Blood-Brain Barrier Transport Drugs market, Blood-Brain Barrier Transport Drugs product introduction, recent developments, etc.
The major vendors covered:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics
1 Blood-Brain Barrier Transport Drugs Market Overview
1.1 Blood-Brain Barrier Transport Drugs Product Scope
1.2 Blood-Brain Barrier Transport Drugs Segment by Type
1.2.1 Global Blood-Brain Barrier Transport Drugs Sales by Type (2020-2026)
1.2.2 Carrier-mediated Transport
1.2.3 Receptor-mediated Transport
1.2.4 Absorptive-mediated Transport
1.2.5 Active Efflux Transport
1.2.6 Others
1.3 Blood-Brain Barrier Transport Drugs Segment by Application
1.3.1 Global Blood-Brain Barrier Transport Drugs Sales Comparison by Application (2020-2026)
1.3.2 Alzheimer’s Disease
1.3.3 Epilepsy
1.3.4 Parkinson’s Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Blood-Brain Barrier Transport Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Blood-Brain Barrier Transport Drugs Price Trends (2015-2026)
2 Blood-Brain Barrier Transport Drugs Estimate and Forecast by Region
2.1 Global Blood-Brain Barrier Transport Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Blood-Brain Barrier Transport Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Blood-Brain Barrier Transport Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.3 China Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.6 India Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
3 Global Blood-Brain Barrier Transport Drugs Competition Landscape by Players
3.1 Global Top Blood-Brain Barrier Transport Drugs Players by Sales (2015-2020)
3.2 Global Top Blood-Brain Barrier Transport Drugs Players by Revenue (2015-2020)
3.3 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood-Brain Barrier Transport Drugs as of 2019)
3.4 Global Blood-Brain Barrier Transport Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Blood-Brain Barrier Transport Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Blood-Brain Barrier Transport Drugs Players (Opinion Leaders)
4 Global Blood-Brain Barrier Transport Drugs Market Size by Type
4.1 Global Blood-Brain Barrier Transport Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Blood-Brain Barrier Transport Drugs Price by Type (2015-2020)
4.2 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Type (2021-2026)
5 Global Blood-Brain Barrier Transport Drugs Market Size by Application
5.1 Global Blood-Brain Barrier Transport Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Blood-Brain Barrier Transport Drugs Price by Application (2015-2020)
5.2 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Application (2021-2026)
6 United States Blood-Brain Barrier Transport Drugs Market Facts & Figures
6.1 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
6.2 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
6.3 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
7 Europe Blood-Brain Barrier Transport Drugs Market Facts & Figures
7.1 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
8 China Blood-Brain Barrier Transport Drugs Market Facts & Figures
8.1 China Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
8.2 China Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
8.3 China Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
9 Japan Blood-Brain Barrier Transport Drugs Market Facts & Figures
9.1 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Blood-Brain Barrier Transport Drugs Market Facts & Figures
10.1 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
11 India Blood-Brain Barrier Transport Drugs Market Facts & Figures
11.1 India Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
11.2 India Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
11.3 India Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Blood-Brain Barrier Transport Drugs Business
12.1 Cyclenium
12.1.1 Cyclenium Corporation Information
12.1.2 Cyclenium Business Overview
12.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
12.1.5 Cyclenium Recent Development
12.2 BioAdvance
12.2.1 BioAdvance Corporation Information
12.2.2 BioAdvance Business Overview
12.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Products Offered
12.2.5 BioAdvance Recent Development
12.3 EIP Pharma
12.3.1 EIP Pharma Corporation Information
12.3.2 EIP Pharma Business Overview
12.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.3.5 EIP Pharma Recent Development
12.4 Bioasis
12.4.1 Bioasis Corporation Information
12.4.2 Bioasis Business Overview
12.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bioasis Blood-Brain Barrier Transport Drugs Products Offered
12.4.5 Bioasis Recent Development
12.5 Immune Pharmaceuticals
12.5.1 Immune Pharmaceuticals Corporation Information
12.5.2 Immune Pharmaceuticals Business Overview
12.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Products Offered
12.5.5 Immune Pharmaceuticals Recent Development
12.6 AZ Therapies
12.6.1 AZ Therapies Corporation Information
12.6.2 AZ Therapies Business Overview
12.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Products Offered
12.6.5 AZ Therapies Recent Development
12.7 Palobiofarma
12.7.1 Palobiofarma Corporation Information
12.7.2 Palobiofarma Business Overview
12.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Products Offered
12.7.5 Palobiofarma Recent Development
12.8 Bach Pharma
12.8.1 Bach Pharma Corporation Information
12.8.2 Bach Pharma Business Overview
12.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.8.5 Bach Pharma Recent Development
12.9 BrainsGate
12.9.1 BrainsGate Corporation Information
12.9.2 BrainsGate Business Overview
12.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Products Offered
12.9.5 BrainsGate Recent Development
12.10 CarThera
12.10.1 CarThera Corporation Information
12.10.2 CarThera Business Overview
12.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CarThera Blood-Brain Barrier Transport Drugs Products Offered
12.10.5 CarThera Recent Development
12.11 Dainippon Sumitomo Pharma
12.11.1 Dainippon Sumitomo Pharma Corporation Information
12.11.2 Dainippon Sumitomo Pharma Business Overview
12.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.11.5 Dainippon Sumitomo Pharma Recent Development
12.12 Fluorinov Pharma
12.12.1 Fluorinov Pharma Corporation Information
12.12.2 Fluorinov Pharma Business Overview
12.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.12.5 Fluorinov Pharma Recent Development
12.13 Fondazione Telethon
12.13.1 Fondazione Telethon Corporation Information
12.13.2 Fondazione Telethon Business Overview
12.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Products Offered
12.13.5 Fondazione Telethon Recent Development
12.14 Minoryx
12.14.1 Minoryx Corporation Information
12.14.2 Minoryx Business Overview
12.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Minoryx Blood-Brain Barrier Transport Drugs Products Offered
12.14.5 Minoryx Recent Development
12.15 NewGen Therapeutics
12.15.1 NewGen Therapeutics Corporation Information
12.15.2 NewGen Therapeutics Business Overview
12.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Products Offered
12.15.5 NewGen Therapeutics Recent Development
13 Blood-Brain Barrier Transport Drugs Manufacturing Cost Analysis
13.1 Blood-Brain Barrier Transport Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
13.4 Blood-Brain Barrier Transport Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Blood-Brain Barrier Transport Drugs Distributors List
14.3 Blood-Brain Barrier Transport Drugs Customers
15 Market Dynamics
15.1 Blood-Brain Barrier Transport Drugs Market Trends
15.2 Blood-Brain Barrier Transport Drugs Opportunities and Drivers
15.3 Blood-Brain Barrier Transport Drugs Market Challenges
15.4 Blood-Brain Barrier Transport Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Blood-Brain Barrier Transport Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Region (2015-2020)
Table 5. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Blood-Brain Barrier Transport Drugs Revenue Share by Region (2015-2020)
Table 8. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Blood-Brain Barrier Transport Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Blood-Brain Barrier Transport Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Blood-Brain Barrier Transport Drugs (K Pcs) of Key Companies (2015-2020)
Table 13. Global Blood-Brain Barrier Transport Drugs Sales Share by Company (2015-2020)
Table 14. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Blood-Brain Barrier Transport Drugs Revenue Share by Company (2015-2020)
Table 16. Global Blood-Brain Barrier Transport Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood-Brain Barrier Transport Drugs as of 2019)
Table 17. Global Blood-Brain Barrier Transport Drugs Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Blood-Brain Barrier Transport Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Blood-Brain Barrier Transport Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Blood-Brain Barrier Transport Drugs Players
Table 22. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 23. Global Blood-Brain Barrier Transport Drugs Sales Share by Type (2015-2020)
Table 24. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Blood-Brain Barrier Transport Drugs Price (K Pcs) by Type (2015-2020)
Table 26. Global Blood-Brain Barrier Transport Drugs Sales Share by Type (2021-2026)
Table 27. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Blood-Brain Barrier Transport Drugs Revenue Share by Type (2021-2026)
Table 29. Global Blood-Brain Barrier Transport Drugs Price (K Pcs) by Type (2021-2026)
Table 30. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2015-2020)
Table 31. Global Blood-Brain Barrier Transport Drugs Sales Share by Application (2015-2020)
Table 32. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Blood-Brain Barrier Transport Drugs Price (K Pcs) by Application (2015-2020)
Table 34. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2021-2026)
Table 35. Global Blood-Brain Barrier Transport Drugs Sales Share by Application (2021-2026)
Table 36. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Blood-Brain Barrier Transport Drugs Revenue Share by Application (2021-2026)
Table 38. Global Blood-Brain Barrier Transport Drugs Price (K Pcs) by Application (2021-2026)
Table 39. United States Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Company (2015-2020)
Table 40. United States Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 42. United States Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2015-2020)
Table 44. United States Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 51. China Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Company (2015-2020)
Table 52. China Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
Table 53. China Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 54. China Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 55. China Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2015-2020)
Table 56. China Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
Table 69. India Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Company (2015-2020)
Table 70. India Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
Table 71. India Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type (2015-2020)
Table 72. India Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
Table 73. India Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application (2015-2020)
Table 74. India Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
Table 75. Cyclenium Corporation Information
Table 76. Cyclenium Description and Business Overview
Table 77. Cyclenium Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Cyclenium Blood-Brain Barrier Transport Drugs Product
Table 79. Cyclenium Recent Development
Table 80. BioAdvance Corporation Information
Table 81. BioAdvance Description and Business Overview
Table 82. BioAdvance Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. BioAdvance Blood-Brain Barrier Transport Drugs Product
Table 84. BioAdvance Recent Development
Table 85. EIP Pharma Corporation Information
Table 86. EIP Pharma Description and Business Overview
Table 87. EIP Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. EIP Pharma Blood-Brain Barrier Transport Drugs Product
Table 89. EIP Pharma Recent Development
Table 90. Bioasis Corporation Information
Table 91. Bioasis Description and Business Overview
Table 92. Bioasis Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bioasis Blood-Brain Barrier Transport Drugs Product
Table 94. Bioasis Recent Development
Table 95. Immune Pharmaceuticals Corporation Information
Table 96. Immune Pharmaceuticals Description and Business Overview
Table 97. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product
Table 99. Immune Pharmaceuticals Recent Development
Table 100. AZ Therapies Corporation Information
Table 101. AZ Therapies Description and Business Overview
Table 102. AZ Therapies Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. AZ Therapies Blood-Brain Barrier Transport Drugs Product
Table 104. AZ Therapies Recent Development
Table 105. Palobiofarma Corporation Information
Table 106. Palobiofarma Description and Business Overview
Table 107. Palobiofarma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Palobiofarma Blood-Brain Barrier Transport Drugs Product
Table 109. Palobiofarma Recent Development
Table 110. Bach Pharma Corporation Information
Table 111. Bach Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Bach Pharma Description and Business Overview
Table 113. Bach Pharma Blood-Brain Barrier Transport Drugs Product
Table 114. Bach Pharma Recent Development
Table 115. BrainsGate Corporation Information
Table 116. BrainsGate Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. BrainsGate Description and Business Overview
Table 118. BrainsGate Blood-Brain Barrier Transport Drugs Product
Table 119. BrainsGate Recent Development
Table 120. CarThera Corporation Information
Table 121. CarThera Description and Business Overview
Table 122. CarThera Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. CarThera Blood-Brain Barrier Transport Drugs Product
Table 124. CarThera Recent Development
Table 125. Dainippon Sumitomo Pharma Corporation Information
Table 126. Dainippon Sumitomo Pharma Description and Business Overview
Table 127. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product
Table 129. Dainippon Sumitomo Pharma Recent Development
Table 130. Fluorinov Pharma Corporation Information
Table 131. Fluorinov Pharma Description and Business Overview
Table 132. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product
Table 134. Fluorinov Pharma Recent Development
Table 135. Fondazione Telethon Corporation Information
Table 136. Fondazione Telethon Description and Business Overview
Table 137. Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Fondazione Telethon Blood-Brain Barrier Transport Drugs Product
Table 139. Fondazione Telethon Recent Development
Table 140. Minoryx Corporation Information
Table 141. Minoryx Description and Business Overview
Table 142. Minoryx Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Minoryx Blood-Brain Barrier Transport Drugs Product
Table 144. Minoryx Recent Development
Table 145. NewGen Therapeutics Corporation Information
Table 146. NewGen Therapeutics Description and Business Overview
Table 147. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product
Table 149. NewGen Therapeutics Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Blood-Brain Barrier Transport Drugs Distributors List
Table 153. Blood-Brain Barrier Transport Drugs Customers List
Table 154. Blood-Brain Barrier Transport Drugs Market Key Trends
Table 155. Blood-Brain Barrier Transport Drugs Key Opportunities and Drivers
Table 156. Blood-Brain Barrier Transport Drugs Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood-Brain Barrier Transport Drugs Product Picture
Figure 2. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Blood-Brain Barrier Transport Drugs Market Share by Application in 2020 & 2026
Figure 6. Alzheimer's Disease Examples
Figure 7. Epilepsy Examples
Figure 8. Parkinson's Disease Examples
Figure 9. Multiple Sclerosis Examples
Figure 10. Hunter's Syndrome Examples
Figure 11. Brain Cancer Examples
Figure 12. Others Examples
Figure 13. Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 14. Global Blood-Brain Barrier Transport Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global Blood-Brain Barrier Transport Drugs Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 16. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States Blood-Brain Barrier Transport Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 20. Europe Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe Blood-Brain Barrier Transport Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China Blood-Brain Barrier Transport Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan Blood-Brain Barrier Transport Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Blood-Brain Barrier Transport Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India Blood-Brain Barrier Transport Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest Blood-Brain Barrier Transport Drugs Players Market Share by Revenue in Blood-Brain Barrier Transport Drugs 2015 & 2019
Figure 31. Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Blood-Brain Barrier Transport Drugs Revenue Share by Type (2015-2020)
Figure 33. Global Blood-Brain Barrier Transport Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global Blood-Brain Barrier Transport Drugs Revenue Share by Application (2015-2020)
Figure 35. Global Blood-Brain Barrier Transport Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 37. United States Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 38. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Company in 2019
Figure 39. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 40. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Application in 2019
Figure 41. China Blood-Brain Barrier Transport Drugs Sales Market Share by Company in 2019
Figure 42. China Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 43. China Blood-Brain Barrier Transport Drugs Sales Market Share by Application in 2019
Figure 44. Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Company in 2019
Figure 45. Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 46. Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Application in 2019
Figure 47. Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Company in 2019
Figure 48. Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 49. Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Application in 2019
Figure 50. India Blood-Brain Barrier Transport Drugs Sales Market Share by Company in 2019
Figure 51. India Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2019
Figure 52. India Blood-Brain Barrier Transport Drugs Sales Market Share by Application in 2019
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Blood-Brain Barrier Transport Drugs
Figure 55. Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
Figure 56. Blood-Brain Barrier Transport Drugs Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
電子輸送層材料の世界市場レポート2020 Market Analysis and Insights: Global Electron Transport Layer Material Market The global Electron Transport Layer Material market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Electron Transport Layer Material Scope and Mark…- 核磁気共鳴画像法（MRI）トランスポートの世界市場レポート2020 Magnetic Resonance Imaging Transport is a specific apparatus that are manufactured with specific careand special skills, utilized to transport the MRI patients with great care. It is made up of no magneticmaterials as MRI consumes magnetic and radio waves. MRI is useful in detecting various acute di…
- 輸送用冷凍ユニット（TRU）の世界市場レポート2020 Transport Refrigeration Units (TRU) is powered by diesel internal combustion engines and are designed to refrigerate or heat perishable goods that are transported in various containers. Significant numbers of these units congregate at distribution centers, truck stops, and other facilities, emitting…
- 極低温液体輸送車両の世界市場レポート2020 Market Analysis and Insights: Global Cryogenic Liquid Transport Vehicles Market The global Cryogenic Liquid Transport Vehicles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cryogenic Liquid Transport Vehicles Scope an…
- 光伝送ネットワーク（OTN）機器の世界市場レポート2020 Optical transport network (OTN) equipment is a range of equipment for optical transmission network(OTN), can generally be divided to OTN transport equipment and OTN switching equipment. Many companies have several plants, usually close to aimed consumption market. The optical transport network (OTN)…